MUFG Americas’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-64
Closed -$1K 937
2017
Q4
$1K Sell
64
-39
-38% -$728 ﹤0.01% 1012
2017
Q3
$2K Hold
103
﹤0.01% 1046
2017
Q2
$2K Buy
103
+48
+87% +$916 ﹤0.01% 1060
2017
Q1
$1K Hold
55
﹤0.01% 1104
2016
Q4
$1K Sell
55
-65
-54% -$1.64K ﹤0.01% 1063
2016
Q3
$4K Sell
120
-60
-33% -$1.78K ﹤0.01% 1005
2016
Q2
$5K Buy
+180
New +$4.06K ﹤0.01% 1011

Other funds holding MGNX

MUFG Americas's MGNX Position: Q1 2018 in Review

MUFG Americas sold out of MacroGenics (MGNX) in Q1 2018, closing a stake of 64 shares — an estimated $1K sold.

MUFG Americas first reported a position in MGNX in Q2 2016 and held it in 7 quarters. The position peaked at $5K in Q2 2016. 132 funds tracked by Wall St. Rank hold MGNX as of Q1 2018.

  • MUFG Americas reported no remaining MacroGenics position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 64 MacroGenics shares in Q1 2018, an estimated $1K.
  • MUFG Americas first reported a position in MacroGenics in Q2 2016 and held it in 7 quarters.
  • MUFG Americas's MacroGenics position peaked at $5K in Q2 2016.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.